Alkem Laboratories

Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, India that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India.

Alkem Laboratories Limited
TypePublic
BSE: 539523
NSE: ALKEM
IndustryPharmaceuticals
Founded1973
FounderSamprada Singh
Headquarters
Mumbai, Maharashtra
,
India
Key people
Basudeo Narayan Singh (Executive Chairman)
Sandeep Singh (MD)
ProductsPharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health
Revenue₹84,485 million (US$1.2 billion) (2020)[1]
₹12,597 million (US$180 million) (2020)[1]
₹11,270 million (US$160 million) (2020)[1]
Total assets₹99,433 million (US$1.4 billion) (2020)[1]
Total equity₹63,089 million (US$880 million) (2020)[1]
Number of employees
14,000 (2020)[1]
Websitewww.alkemlabs.com

Company

Alkem set up its research and development facility for ANDA development at Taloja in 2003. In 2006 anti-infective drug Taxim of Alkem became the first anti-infective drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India. In 2014 Clavam other drug from Alkem crossed 2,000 million mark in terms of domestic sales in India. In 2007 the company filed its first ANDA for drug Amlodipine which was approved in 2009. Alkem has developed a portfolio of 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015 and a portfolio of 705 brands in India in the six months ended 30 September 2015. Alkem have 21 manufacturing facilities, 19 in India and 2 in US. 5 of the facilities are US FDA, TGA, UK MHRA approved.

Acquisitions

Alkem has 21 manufacturing facilities: 19 in India and 2 in the US. These 2 facilities in the US were acquired in 2012 and 2013 respectively. In 2014 acquired the "Clindac-A" brand in India from Galderma S.A. In 2015, Alkem acquired a formulation manufacturing facility in the US.

Governance and administration

Samprada Singh was the founder and chairman emeritus of the company, he led and shaped Alkem what it is today, he had a B.Com degree from Patna University. He was the 42nd richest person in India and a billionaire.[2] His brother, Basudeo Narayan Singh,[3] was also the co-founder of the company. Samprada Singh died on 27 July 2019 at the age of 94 years after a brief illness in Mumbai.[4]

PositionName
Founder Chairman EmeritusMr. Samprada Singh
Executive ChairmanMr.Basudeo Narayan Singh
Joint Managing DirectorMr.Dhananjay Kumar Singh
Joint Managing DirectorMr.Sandeep Singh
Independent DirectorDr.Dheeraj Sharma
Independent DirectorMr.A.K. Purwar
Independent DirectorMr.N. K. Aneja
Independent DirectorMr.R. L. Shenoy
Independent DirectorMs.Sangeeta Singh
Independent DirectorMs.Sudha Ravi

[5]

References
  1. "Alkem Laboratories Limited Annual Report 2020" (PDF). Alkem Laboratories Limited. Retrieved 2 July 2020.
  2. "Samprada Singh & family". Forbes.
  3. "Basudeo Singh". Bloomberg.
  4. "Alkem Labs Founder Samprada Singh passes away at the age of 92 years". Medical Dialogues. 27 July 2019.
  5. "Board of Directors". Alkem.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.